Novartis
Search results
- Open37.33High37.50Low37.03
- Mkt Cap16.01BP/E (TTM)N/ADiv & Yield0.45 & 1.21%
- Prev. Close37.2752 Wk. Low22.7052 Wk. High38.52
Related stocks
Open | 37.33 |
High | 37.50 |
Low | 37.03 |
Mkt Cap | 16.01B |
P/E (TTM) | N/A |
Div & Yield | 0.45 & 1.21% |
Prev. Close | 37.27 |
52 Wk. Low | 22.70 |
52 Wk. High | 38.52 |
Related stocks
Pharmaceutical company
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 2.53B | 2.70% ▲ |
Net Income | 75M | 36.20% ▼ |
Diluted EPS | 36.20% ▼ |
S&P 500^GSPC | 5,554.25+11.03 (+0.20%) |
Dow 30^DJI | 40,659.76+96.70 (+0.24%) |
Nasdaq^IXIC | 17,631.72+37.22 (+0.21%) |
fuboTV Inc.FUBO | 1.5300+16.79% |
7.06+110.75% | |
Gold Dec 24GC=F | 2,546.20+2.16% |